The application window for our innovation call with LabCentral is now open. Anchored with the Bio Innovation Hub (BIH), this is the sixth year that Novo Nordisk and LabCentral are working together to support the life sciences ecosystem in Boston.
In addition to offering two Golden Tickets at LabCentral this year, the BIH is also accepting applications for opportunities to work with Novo Nordisk on a collaboration.
What opportunities are available through this innovation call with LabCentral?
Novo Nordisk’s Bio Innovation Hub is interested in exploring co-creation opportunities with startups that are developing platform technologies with disease agnostic potential as well as projects within the cardiometabolic space or translatability to this space.
